Anthony Farina is Chief Communications Officer & Global Corporate Affairs Leader at CSL Behring—now the world’s third-largest biotechnology leader.  Earlier this month, CSL Behring announced the formation of a new alliance with Japan’s Takeda Pharmaceutical Company and other international partners to develop a potential plasma-derived therapy for treating COVID-19.  He commented that “Unprecedented times call for unprecedented actions. This new alliance brings together the expertise of industry leaders worldwide for scale, sustainability, and reliability.”